Back

Assessing cancer therapy-related cardiac dysfunction risk in non-Hodgkin lymphoma patients, the role of comprehensive echocardiographic monitoring

12 December 2025 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology: what are the new imaging insights? Systolic and Diastolic Function EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Daniela Bursacovschi

Institute of Cardiology, Chisinau (Moldova (Republic of))

6 More presentations in this session

Presentation thumbnail
Under pressure: right ventricular and right atrial strain predict in-hospital death in cancer patients with pulmonary embolism
Doctor A. Vijiiac (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Predictive value of global longitudinal strain (GLS) in breast cancer patients undergoing trastuzumab-based chemotherapy
Doctor V. Dimitrova (Sofia, BG)
Abstract Slides
Presentation thumbnail
Risk prediction model for early left ventricular systolic dysfunction in breast cancer patients when the global longitudinal strain is not available
Doctor A. Stevanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Right ventricular dysfunction and mortality in breast cancer patients treated with anthracyclines: a retrospective cohort study
Doctor N. Sari (Jakarta, ID)
Abstract Slides
Presentation thumbnail
Semaglutide preserves myocardial function in a murine model of sequential anthracycline trastuzumab induced early cardiotoxicity: insights from speckle tracking echocardiography
Doctor N. Maurea (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardio-oncology: what are the new imaging insights?

The Event

Event poster

EACVI 2025

12 December 2025 11:30 CET
You may be interested in
thumbnail
Congress Session
Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
Threshold values for diastolic dysfunction parameters indicative of increased mortality risk in a real-world patient cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources